Hello and Welcome to Patientsville.com, Your Source for all MEFOXIN information. We are dedicated to provide You with MEFOXIN safety information. Learn about MEFOXIN serious adverse events reported to Food and Drug Administration (FDA).
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
MEFOXIN Safety Reports
Total MEFOXIN reports: 6.MEFOXIN FDA safety alerts: No.
Reported deaths: 3 Reported hospitalizations: 3.
Take MEFOXIN Side Effects Survey or Share Your MEFOXIN Story. Read More Here.
Health Professional from UNITED STATES reported MEFOXIN problem on Jan 05, 2007. Female patient, 53 years of age, was diagnosed with prophylaxis and was treated with MEFOXIN. After drug was administered, patient experienced the following problems/side effects: pyrexia, rash morbilliform. MEFOXIN dosage: unknown. Patient recovered.
MEFOXIN problem was reported by a Physician from UNITED STATES on Jan 24, 2007. Male patient, 29 years of age, was diagnosed with prophylaxis and was treated with MEFOXIN. After drug was administered, patient experienced the following problems/side effects: bed rest, blood potassium decreased, dehydration, diarrhoea, pulmonary embolism, pyrexia, shock. MEFOXIN dosage: unknown. During the same period patient was treated with PRILOSEC, REGLAN, DULCOLAX. Patient was hospitalized and became disabled. Patient died on 12/26/1999.
Physician from UNITED STATES reported MEFOXIN problem on Mar 22, 2007. Female patient, 53 years of age, was diagnosed with prophylaxis and was treated with MEFOXIN. After drug was administered, patient experienced the following problems/side effects: pyrexia, rash morbilliform. MEFOXIN dosage: unknown. Patient recovered.
MEFOXIN problem was reported by a Health Professional from FRANCE on July 10, 2006. Female patient, 70 years of age, was diagnosed with infection prophylaxis and was treated with MEFOXIN. After drug was administered, patient experienced the following problems/side effects: bronchospasm, hypotension, rash. MEFOXIN dosage: unknown. During the same period patient was treated with SUCCINYLCHOLINE IODIDE, PROPOFOL, CISATRACURIUM BESYLATE, SUFENTANIL CITRATE, NEFOPAM HYDROCHLORIDE. Patient recovered.
Physician from UNITED STATES reported MEFOXIN problem on Aug 30, 2006. Female patient, 21 years of age, was diagnosed with mycobacterium abscessus infection and was treated with MEFOXIN. After drug was administered, patient experienced the following problems/side effects: breast prosthesis user, cardiac arrest, enterococcal infection, erythema multiforme, hypotension, implant site effusion, incision site infection, lung infection. MEFOXIN dosage: unknown. During the same period patient was treated with VALGANCICLOVIR HYDROCHLORIDE, AMIKACIN, KANAMYCIN. Patient was hospitalized. Patient died.
MEFOXIN problem was reported by a Physician from UNITED STATES on Aug 30, 2006. Female patient, 21 years of age, was diagnosed with mycobacterium abscessus infection and was treated with MEFOXIN. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, erythema multiforme, mycobacterial infection, seroma, skin infection. MEFOXIN dosage: unknown. During the same period patient was treated with VALGANCICLOVIR HYDROCHLORIDE, AMIKACIN, KANAMYCIN. Patient was hospitalized. Patient died.